DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
” - 1 Sharon Chinthrajah - 1 “ - 1 ” Xolair - 1 Robert Wood - 1 ” Wood - 1 Xolair - 1 Wood - 1
Top related locs:
Washington The anaphylaxis Eudowood Johns University of South Florida Tampa
Top related orgs:
Immunology - 2 of Medicine - 2 Food and Drug Administration - 1 American Academy of Allergy - 1 Asthma - 1 The New England - 1 CNN - 1 New England - 1

Search resuls for: "American Academy of Allergy"


2 mentions found


☆ Drug Drastically Reduces Children’s Reactions to Traces of Food Allergens
  + stars: | 2024-02-25 | by ( Roni Caryn Rabin | ) www.nytimes.com   time to read: 1 min
A drug that has been used for decades to treat allergic asthma and hives significantly reduced the risk of life-threatening reactions in children with severe food allergies who were exposed to trace amounts of peanuts, cashews, milk and eggs, researchers reported on Sunday. The drug, Xolair, has already been approved by the Food and Drug Administration for adults and children over age 1 with food allergies. It is the first treatment that drastically cuts the risk of serious reactions — like anaphylaxis, a life-threatening allergic reaction that causes the body to go into shock — after accidental exposures to various food allergens. The results of the researchers’ study, presented at the annual conference of the American Academy of Allergy, Asthma and Immunology in Washington, were published in The New England Journal of Medicine.
Organizations: Food and Drug Administration, American Academy of Allergy, Asthma, Immunology, The New England, of Medicine Locations: Washington, The
☆ New data shows asthma medicine may help reduce severe reactions in people with multiple food allergies
  + stars: | 2024-02-25 | by ( Amanda Musa | ) edition.cnn.com   time to read: +9 min
CNN —A new study finds that the asthma medication Xolair may substantially reduce severe allergic reactions in people who have multiple food allergies and are accidentally exposed to those foods. There is no cure for food allergies, and the only other FDA-approved treatment is Palforzia, an oral immunotherapy for peanut allergies in children between 4 and 17 years old. “But the reality is that most of our patients don’t just have peanut allergy,” Wood added. For people who have multiple severe food allergies and even moderate to severe allergic asthma, Casale says, Xolair might be the best treatment option. Xolair does not eliminate food allergies, and unlike with some environmental allergies such as pollen, many people never outgrow them, Casale added.
Persons: ”, Sharon Chinthrajah, “, ” Xolair, Robert Wood, ” Wood, Xolair, Wood, omalizumab, Thomas Casale, Palforzia, Casale, they’ve, ” Lindsey Mathias, Dr, Sanjay Gupta, Chinthrajah, “ We’re Organizations: CNN, New England, of Medicine, US Food and Drug Administration, Stanford University, of Allergy, Immunology, Johns Hopkins Children’s, Genentech, Novartis, FDA, National Institutes of Health, University of South, American Academy of Allergy Asthma, CNN Health, Xolair Locations: anaphylaxis, Eudowood, Johns, University of South Florida Tampa
0 next >>
Total: 2